Helix Energy Reports Q4 2025 Earnings with Mixed Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 24 2026
0mins
Should l Buy HLX?
Source: NASDAQ.COM
Helix Energy Solutions Group Inc's stock surged by 16.54% as it reached a 52-week high, reflecting investor optimism despite mixed financial results.
The company reported a GAAP EPS of $0.06 for Q4 2025, exceeding expectations by $0.05, but faced a staggering 90.4% year-over-year revenue decline to $34.16 million, missing market expectations significantly. Additionally, the resignation of the CEO may impact future strategic direction, but the company secured a multi-year P&A contract in the UK North Sea, indicating potential growth opportunities.
Despite the challenges, Helix's ability to generate over $100 million in free cash flow during the quarter demonstrates effective cash flow management. Investors are likely to keep a close eye on the company's strategic moves following the CEO's departure.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLX
Wall Street analysts forecast HLX stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 9.830
Low
12.00
Averages
12.00
High
12.00
Current: 9.830
Low
12.00
Averages
12.00
High
12.00
About HLX
Helix Energy Solutions Group, Inc. is an international offshore energy services company that provides specialty services to the offshore energy industry, with a focus on well intervention, robotics and decommissioning operations. Its services are key in supporting a global energy transition by maximizing production of existing oil and gas reserves, decommissioning end-of-life oil and gas fields and supporting renewable energy developments. Its segments include Well Intervention, Robotics, and Production Facilities. Its Well Intervention segment provides services enabling its customers to safely access subsea offshore wells for the purpose of performing production enhancement or decommissioning operations. Its Robotics segment provides trenching, seabed clearance, offshore construction and inspection, repair and maintenance (IRM) services to both the oil and gas and the renewable energy markets globally. Its robotics services are used in and complement its well intervention services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Helix Energy Solutions Group, Inc. and Hornbeck Offshore Services, Inc., with Helix shareholders expected to own approximately 45% of the combined entity, potentially impacting shareholder rights and future earnings.
- Acquisition Review: Organon & Co. is being sold to Sun Pharmaceutical Industries Limited for $14.00 per share, and Halper Sadeh LLC may seek increased compensation and additional disclosures to ensure shareholder rights are protected.
- Equity Transaction: XOMA Royalty Corporation is being sold to Ligand Pharmaceuticals Incorporated for $39.00 per share, with Halper Sadeh LLC representing shareholders to investigate the compliance of this transaction and ensure fair terms for shareholders.
- RE/MAX Deal: RE/MAX Holdings, Inc. is in a transaction with The Real Brokerage Inc., allowing shareholders to choose either 5.152 shares or $13.80 in cash per share, with Halper Sadeh LLC providing legal support to safeguard shareholder interests.
See More
Investigation Alerts for Multiple Company Mergers
- Helix Merger Investigation: Helix Energy Solutions is set to be acquired by Hornbeck Offshore Services, with Helix shareholders expected to own approximately 45% of the combined entity, raising concerns about whether the Helix Board breached fiduciary duties by failing to ensure a fair process in the transaction.
- TopBuild Acquisition Details: TopBuild will be acquired by QXO, allowing shareholders to choose between $505 in cash or 20.2 shares of QXO stock per TopBuild share, with the deal's total consideration being approximately 45% cash and 55% stock, prompting investigations into whether the transaction offers fair value, especially as it falls below the 52-week high of $559.47.
- Avanos Acquisition Situation: Avanos is being acquired by American Industrial Partners for $25.00 per share, amounting to an enterprise value of approximately $1.272 billion, with investigations focusing on whether the Avanos Board failed to conduct a fair process to ensure shareholder value in the deal.
- Affinity Bancshares Transaction: Affinity Bancshares will be acquired by Fidelity for $23.00 per share, representing a total transaction value of approximately $142.8 million, with investigations examining whether the Board breached fiduciary duties by not ensuring the fairness of the transaction for shareholders.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation: Halper Sadeh LLC is investigating Soleno Therapeutics, Inc. (NASDAQ: SLNO) regarding its sale to Neurocrine Biosciences for $53.00 per share, which may involve violations of shareholder rights.
- Shareholder Rights Protection: The transaction between Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) and Biogen Inc. includes $41.00 per share in cash and two non-transferable rights of $2.00 each, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
- Merger Impact: Helix Energy Solutions Group, Inc. (NYSE: HLX) is merging with Hornbeck Offshore Services, Inc., resulting in Helix shareholders owning approximately 45% of the combined entity, prompting Halper Sadeh LLC to assess the implications for shareholders.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, allowing shareholders to consult on their rights and options without upfront costs, ensuring their legal interests are protected.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde Law Firm is investigating Citizens National Corporation (CZNL) related to its sale to Peoples Bancorp, Inc., where shareholders are expected to receive 2.10 common shares of Peoples and $8.00 in cash per share, aiming to ensure fair compensation for shareholders in the transaction.
- Merger Transaction Analysis: Helix Energy Solutions Group, Inc. (HLX) is merging with Hornbeck Offshore Services, Inc., which will allow Helix shareholders to own approximately 45% of the combined company, indicating strong competitive positioning post-merger.
- Pharmaceutical Acquisition Dynamics: Apellis Pharmaceuticals, Inc. (APLS) is set to be acquired by Biogen, Inc., with shareholders expected to receive $41.00 per share in cash and two contingent payments of $2.00 each, reflecting confidence in meeting future sales targets.
- Biotech Transaction Progress: Soleno Therapeutics, Inc. (SLNO) is being acquired by Neurocrine Biosciences, Inc., with shareholders expected to receive $53.00 per share in cash, and a shareholder vote scheduled for May 15, 2026, showcasing the company's proactive strategy in the biotech sector.
See More
Three Stocks to Watch Under $50
- Insteel Performance Warning: Insteel (IIIN) trades at $26.14, with a mere 5.9% annual revenue growth over the past five years, lagging behind industry peers, indicating a potential decline in market competitiveness that could undermine investor confidence.
- Helix Energy Competitive Disadvantage: Helix Energy Solutions (HLX) is priced at $10.30, with a revenue base of $1.3 billion and a gross margin of only 11.4%, significantly lower than competitors, which restricts its investment capabilities in exploration and production, potentially leading to long-term growth challenges.
- Hims & Hers Growth Potential: Hims & Hers Health (HIMS) is priced at $27.43, boasting a customer growth rate of 29.5% over the past two years and a 16.9 percentage point increase in free cash flow margin, showcasing strong growth potential in the market that may attract more investor interest.
- Market Dynamics Analysis: Stocks priced between $10 and $50 often include mid-sized companies that typically carry lower risk; however, careful assessment of their growth potential and market competitiveness is essential to avoid investment pitfalls.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating TruBridge, Inc. (NASDAQ: TBRG) regarding its sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, which may infringe on shareholder rights.
- Merger Transactions: Helix Energy Solutions Group, Inc. (NYSE: HLX) is merging with Hornbeck Offshore Services, Inc., resulting in Helix shareholders owning approximately 45% of the combined entity, potentially affecting shareholder control.
- Shareholder Rights: Allegiant Travel Company (NASDAQ: ALGT) is merging with Sun Country Airlines, allowing Allegiant shareholders to hold about 67% of the combined company, prompting Halper Sadeh LLC to remind shareholders to be aware of their rights.
- Legal Support: FONAR Corporation (NASDAQ: FONR) is selling to executives for $19.00 per share for Class B and $6.34 for Class C stock, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Helix Energy Solutions Group, Inc. and Hornbeck Offshore Services, Inc., with Helix shareholders expected to own approximately 45% of the combined entity, potentially impacting shareholder rights and future earnings.
- Acquisition Review: Organon & Co. is being sold to Sun Pharmaceutical Industries Limited for $14.00 per share, and Halper Sadeh LLC may seek increased compensation and additional disclosures to ensure shareholder rights are protected.
- Equity Transaction: XOMA Royalty Corporation is being sold to Ligand Pharmaceuticals Incorporated for $39.00 per share, with Halper Sadeh LLC representing shareholders to investigate the compliance of this transaction and ensure fair terms for shareholders.
- RE/MAX Deal: RE/MAX Holdings, Inc. is in a transaction with The Real Brokerage Inc., allowing shareholders to choose either 5.152 shares or $13.80 in cash per share, with Halper Sadeh LLC providing legal support to safeguard shareholder interests.
See More
Investigation Alerts for Multiple Company Mergers
- Helix Merger Investigation: Helix Energy Solutions is set to be acquired by Hornbeck Offshore Services, with Helix shareholders expected to own approximately 45% of the combined entity, raising concerns about whether the Helix Board breached fiduciary duties by failing to ensure a fair process in the transaction.
- TopBuild Acquisition Details: TopBuild will be acquired by QXO, allowing shareholders to choose between $505 in cash or 20.2 shares of QXO stock per TopBuild share, with the deal's total consideration being approximately 45% cash and 55% stock, prompting investigations into whether the transaction offers fair value, especially as it falls below the 52-week high of $559.47.
- Avanos Acquisition Situation: Avanos is being acquired by American Industrial Partners for $25.00 per share, amounting to an enterprise value of approximately $1.272 billion, with investigations focusing on whether the Avanos Board failed to conduct a fair process to ensure shareholder value in the deal.
- Affinity Bancshares Transaction: Affinity Bancshares will be acquired by Fidelity for $23.00 per share, representing a total transaction value of approximately $142.8 million, with investigations examining whether the Board breached fiduciary duties by not ensuring the fairness of the transaction for shareholders.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Legal Investigation: Halper Sadeh LLC is investigating Soleno Therapeutics, Inc. (NASDAQ: SLNO) regarding its sale to Neurocrine Biosciences for $53.00 per share, which may involve violations of shareholder rights.
- Shareholder Rights Protection: The transaction between Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) and Biogen Inc. includes $41.00 per share in cash and two non-transferable rights of $2.00 each, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures for shareholders.
- Merger Impact: Helix Energy Solutions Group, Inc. (NYSE: HLX) is merging with Hornbeck Offshore Services, Inc., resulting in Helix shareholders owning approximately 45% of the combined entity, prompting Halper Sadeh LLC to assess the implications for shareholders.
- Legal Fee Arrangement: Halper Sadeh LLC offers legal services on a contingency fee basis, allowing shareholders to consult on their rights and options without upfront costs, ensuring their legal interests are protected.
See More
Monteverde Law Firm Investigates Multiple Acquisition Cases
- Shareholder Rights Protection: Monteverde Law Firm is investigating Citizens National Corporation (CZNL) related to its sale to Peoples Bancorp, Inc., where shareholders are expected to receive 2.10 common shares of Peoples and $8.00 in cash per share, aiming to ensure fair compensation for shareholders in the transaction.
- Merger Transaction Analysis: Helix Energy Solutions Group, Inc. (HLX) is merging with Hornbeck Offshore Services, Inc., which will allow Helix shareholders to own approximately 45% of the combined company, indicating strong competitive positioning post-merger.
- Pharmaceutical Acquisition Dynamics: Apellis Pharmaceuticals, Inc. (APLS) is set to be acquired by Biogen, Inc., with shareholders expected to receive $41.00 per share in cash and two contingent payments of $2.00 each, reflecting confidence in meeting future sales targets.
- Biotech Transaction Progress: Soleno Therapeutics, Inc. (SLNO) is being acquired by Neurocrine Biosciences, Inc., with shareholders expected to receive $53.00 per share in cash, and a shareholder vote scheduled for May 15, 2026, showcasing the company's proactive strategy in the biotech sector.
See More
Three Stocks to Watch Under $50
- Insteel Performance Warning: Insteel (IIIN) trades at $26.14, with a mere 5.9% annual revenue growth over the past five years, lagging behind industry peers, indicating a potential decline in market competitiveness that could undermine investor confidence.
- Helix Energy Competitive Disadvantage: Helix Energy Solutions (HLX) is priced at $10.30, with a revenue base of $1.3 billion and a gross margin of only 11.4%, significantly lower than competitors, which restricts its investment capabilities in exploration and production, potentially leading to long-term growth challenges.
- Hims & Hers Growth Potential: Hims & Hers Health (HIMS) is priced at $27.43, boasting a customer growth rate of 29.5% over the past two years and a 16.9 percentage point increase in free cash flow margin, showcasing strong growth potential in the market that may attract more investor interest.
- Market Dynamics Analysis: Stocks priced between $10 and $50 often include mid-sized companies that typically carry lower risk; however, careful assessment of their growth potential and market competitiveness is essential to avoid investment pitfalls.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Investigation Background: Halper Sadeh LLC is investigating TruBridge, Inc. (NASDAQ: TBRG) regarding its sale to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, which may infringe on shareholder rights.
- Merger Transactions: Helix Energy Solutions Group, Inc. (NYSE: HLX) is merging with Hornbeck Offshore Services, Inc., resulting in Helix shareholders owning approximately 45% of the combined entity, potentially affecting shareholder control.
- Shareholder Rights: Allegiant Travel Company (NASDAQ: ALGT) is merging with Sun Country Airlines, allowing Allegiant shareholders to hold about 67% of the combined company, prompting Halper Sadeh LLC to remind shareholders to be aware of their rights.
- Legal Support: FONAR Corporation (NASDAQ: FONR) is selling to executives for $19.00 per share for Class B and $6.34 for Class C stock, with Halper Sadeh LLC potentially seeking increased compensation and additional disclosures to protect shareholder interests.
See More
